Liu Der-Zen, Liang Hong-Jen, Chen Chien-Ho, Lin Shyr-Yi, Zhong Wen-Bin, Ho Feng-Ming, Hou Wen-Chi, Lo Jui-Lien, Ho Yuan-Soon, Lin Pei-Jung, Hung Ling-Fang, Liang Yu-Chih
Graduate Institutes of Biomedical Materials, Taipei Medical University, Taipei, Taiwan.
Biochim Biophys Acta. 2007 Jun;1773(6):869-79. doi: 10.1016/j.bbamcr.2007.03.018. Epub 2007 Mar 30.
Phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P(2)) has been known to serve as a substrate for phosphatidylinositol 3-kinase (PI(3)K) and phosphoinositide-specific phospholipase C (PI-PLC), which can produce PtdIns(3,4,5)P(3) and inositol 1,4,5-trisphosphate (Ins(1,4,5)P(3)) and diacylglycerol (DAG), respectively. In this study, we elucidated the role of PI-PLC during the LPS-activated mouse macrophages RAW264.7 treated with PI(3)K inhibitor wortmannin. First, wortmannin treatment enhanced Ins(1,4,5)P(3) production and iNOS expression in LPS-activated macrophages. Inhibition of PI(3)K by p85 siRNA also showed an enhancement of iNOS expression. On the other hand, overexpression of PI(3)K by ras-p110 expression plasmid significantly decreased iNOS expression in LPS-activated macrophages. In addition, overexpression of wild-type or dominant-negative Akt expression plasmid did not affect the iNOS expression in LPS-activated macrophages. Second, treatment of PI-PLC inhibitor U73122 reversed the enhancement of iNOS expression, the increase of phosphorylation level of ERK, JNK and p38, and the increase of AP-1-dependent gene expression in wortmannin-treated and LPS-activated macrophages. However, NF-kappaB activity determined by EMSA assay and reporter plasmid assay did not change during LPS-activated macrophages with or without wortmannin. We propose that the inhibition of PI(3)K by wortmannin in mouse macrophages enhances the PI-PLC downstream signals, and subsequently increases the LPS induction of iNOS expression independently of Akt pathway.
磷脂酰肌醇(4,5)-二磷酸(PtdIns(4,5)P₂)已知可作为磷脂酰肌醇3激酶(PI(3)K)和磷酸肌醇特异性磷脂酶C(PI-PLC)的底物,PI(3)K和PI-PLC分别可产生磷脂酰肌醇(3,4,5)-三磷酸(PtdIns(3,4,5)P₃)、肌醇1,4,5-三磷酸(Ins(1,4,5)P₃)和二酰基甘油(DAG)。在本研究中,我们阐明了PI-PLC在用PI(3)K抑制剂渥曼青霉素处理的LPS激活的小鼠巨噬细胞RAW264.7中的作用。首先,渥曼青霉素处理增强了LPS激活的巨噬细胞中Ins(1,4,5)P₃的产生和诱导型一氧化氮合酶(iNOS)的表达。用p85小干扰RNA抑制PI(3)K也显示iNOS表达增强。另一方面,通过ras-p110表达质粒过表达PI(3)K显著降低了LPS激活的巨噬细胞中iNOS的表达。此外,野生型或显性负性Akt表达质粒的过表达不影响LPS激活的巨噬细胞中iNOS的表达。其次,PI-PLC抑制剂U73122的处理逆转了渥曼青霉素处理和LPS激活的巨噬细胞中iNOS表达的增强、细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)和p38磷酸化水平的增加以及AP-1依赖性基因表达的增加。然而,在有或没有渥曼青霉素存在的情况下,通过电泳迁移率变动分析(EMSA)和报告质粒分析测定的核因子κB(NF-κB)活性在LPS激活的巨噬细胞中没有变化。我们提出,渥曼青霉素对小鼠巨噬细胞中PI(3)K的抑制增强了PI-PLC下游信号,随后独立于Akt途径增加了LPS诱导的iNOS表达。